雄激素在血液系统中的应用进展
Advances in the Application of Androgens in the Hematologic System
DOI: 10.12677/acm.2025.15123388, PDF,   
作者: 陈泽海, 何钰琨, 何星妤：成都中医药大学临床医学院，四川 成都；刘松山*：成都中医药大学附属医院血液科，四川 成都
关键词: 雄激素；血液系统；临床应用；Androgens； Hematologic System； Clinical Application
摘要: 雄激素作为调节机体造血功能的重要激素，在血液系统疾病治疗中具有明确价值。其临床主要通过促进造血，用于治疗骨髓衰竭性疾病；亦可通过端粒维持治疗其他血液系统疾病；或通过调节免疫细胞或蛋白同化作用影响相关疾病。同时，在临床应用中需注意其风险和副作用。近年来的研究为雄激素的使用提供了新方向，也为特定血液疾病的治疗提供了重要补充策略。
Abstract: Androgens, as important hormones regulating hematopoietic function, have a clear value in the treatment of hematological diseases. Clinically, they mainly promote hematopoiesis and are used to treat bone marrow failure disorders; they can also treat other hematological diseases through telomere maintenance, or affect related diseases by regulating immune cells or protein anabolism. At the same time, attention must be paid to their risks and side effects in clinical applications. Recent research has provided new directions for the use of androgens and has also offered an important supplementary strategy for the treatment of specific hematological diseases.
文章引用：陈泽海, 何钰琨, 何星妤, 刘松山. 雄激素在血液系统中的应用进展[J]. 临床医学进展, 2025, 15(12): 125-131. https://doi.org/10.12677/acm.2025.15123388

参考文献

[1] Warren, A.M. and Grossmann, M. (2022) Haematological Actions of Androgens. Best Practice & Research Clinical Endocrinology & Metabolism, 36, Article ID: 101653. [Google Scholar] [CrossRef] [PubMed]
[2] 云宇, 段为钢. 药理学[M]. 北京: 科学出版社, 2021.
[3] 束怀德. 甾体激素药理学[M]. 北京: 人民卫生出版社, 1982.
[4] 周琦浩, 吴迪炯, 叶宝东, 等. 再生障碍性贫血雄激素治疗选择及研究现状[J]. 临床血液学杂志, 2015, 28(1): 87-89.
[5] Pagliuca, S., Kulasekararaj, A.G., Eikema, D., Piepenbroek, B., Iftikhar, R., Satti, T.M., et al. (2023) Current Use of Androgens in Bone Marrow Failure Disorders: A Report from the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica, 109, 765-776. [Google Scholar] [CrossRef] [PubMed]
[6] Shimano, K.A., Rothman, J.A., Allen, S.W., Castillo, P., de Jong, J.L.O., Dror, Y., et al. (2024) Treatment of Newly Diagnosed Severe Aplastic Anemia in Children: Evidence‐based Recommendations. Pediatric Blood & Cancer, 71, e31070. [Google Scholar] [CrossRef] [PubMed]
[7] Nassani, M., Fakih, R.E., Passweg, J., Cesaro, S., Alzahrani, H., Alahmari, A., et al. (2023) The Role of Androgen Therapy in Acquired Aplastic Anemia and Other Bone Marrow Failure Syndromes. Frontiers in Oncology, 13, Article ID: 1135160. [Google Scholar] [CrossRef] [PubMed]
[8] Calado, R.T. (2023) Bone Marrow Failure on Steroids: When to Use Androgens? Haematologica, 109, 695-697. [Google Scholar] [CrossRef] [PubMed]
[9] 中华医学会血液学分会红细胞疾病(贫血)学组. 再生障碍性贫血诊断与治疗中国指南(2022年版) [J]. 中华血液学杂志, 2022, 43(11): 881-888.
[10] 李红敏, 龙章彪, 王涛, 等. 司坦唑醇和达那唑治疗非重型再生障碍性贫血的疗效及其对CD4 CD25 Foxp3调节性T细胞的影响[J]. 中华血液学杂志, 2022, 43(2): 157-160.
[11] 刘秋霞, 汤静燕. 骨髓衰竭性疾病的诊断与治疗[J]. 中华实用儿科临床杂志, 2012, 27(3): 228-232.
[12] 中华医学会血液学分会红细胞疾病(贫血)学组. 范科尼贫血诊断与治疗中国专家共识(2022版) [J]. 中华医学杂志, 2023, 103(4): 235-241.
[13] 中国老年医学学会血液学分会MDS专委会, 常春康, 肖志坚, 等. 中国老年骨髓增生异常性肿瘤诊断和治疗专家共识(2024版) [J]. 诊断学理论与实践, 2024, 23(3): 285-296.
[14] 中华医学会血液学分会. 骨髓增生异常综合征中国诊断与治疗指南(2019年版) [J]. 中华血液学杂志, 2019, 40(2): 89-97.
[15] 中华医学会血液学分会白血病淋巴瘤学组. 原发性骨髓纤维化诊断与治疗中国指南(2019年版) [J]. 中华血液学杂志, 2019, 40(1): 1-7.
[16] Ziegler, P., Schrezenmeier, H., Akkad, J., Brassat, U., Vankann, L., Panse, J., et al. (2012) Telomere Elongation and Clinical Response to Androgen Treatment in a Patient with Aplastic Anemia and a Heterozygous hTERT Gene Mutation. Annals of Hematology, 91, 1115-1120. [Google Scholar] [CrossRef] [PubMed]
[17] Tometten, M., Beier, F., Kirschner, M., Schumacher, Y., Walter, J., Vieri, M., et al. (2025) Late-Onset Telomere Biology Disorders in Adults: Clinical Insights and Treatment Outcomes from a Retrospective Registry Cohort. Blood Advances, 9, 2183-2191. [Google Scholar] [CrossRef] [PubMed]
[18] Clé, D.V., Catto, L.F.B., Gutierrez-Rodrigues, F., Donaires, F.S., Pinto, A.L., Santana, B.A., et al. (2022) Effects of Nandrolone Decanoate on Telomere Length and Clinical Outcome in Patients with Telomeropathies: A Prospective Trial. Haematologica, 108, 1300-1312. [Google Scholar] [CrossRef] [PubMed]
[19] 李桂芳, 陶陶. 端粒及端粒酶基因与再生障碍性贫血的关系[J]. 国际输血及血液学杂志, 2014, 37(2): 135-137.
[20] Calado, R.T., Yewdell, W.T., Wilkerson, K.L., Regal, J.A., Kajigaya, S., Stratakis, C.A., et al. (2009) Sex Hormones, Acting on the TERT Gene, Increase Telomerase Activity in Human Primary Hematopoietic Cells. Blood, 114, 2236-2243. [Google Scholar] [CrossRef] [PubMed]
[21] Gubbels Bupp, M.R. and Jorgensen, T.N. (2018) Androgen-Induced Immunosuppression. Frontiers in Immunology, 9, Article No. 794. [Google Scholar] [CrossRef] [PubMed]
[22] Hoffmann, J.P., Liu, J.A., Seddu, K. and Klein, S.L. (2023) Sex Hormone Signaling and Regulation of Immune Function. Immunity, 56, 2472-2491. [Google Scholar] [CrossRef] [PubMed]
[23] Bosi, A., Barcellini, W., Passamonti, F. and Fattizzo, B. (2023) Androgen Use in Bone Marrow Failures and Myeloid Neoplasms: Mechanisms of Action and a Systematic Review of Clinical Data. Blood Reviews, 62, Article ID: 101132. [Google Scholar] [CrossRef] [PubMed]
[24] Mylvaganam, R., Ahn, Y.S., Harrington, W.J. and Kim, C.I. (1987) Immune Modulation by Danazol in Autoimmune Thrombocytopenia. Clinical Immunology and Immunopathology, 42, 281-287. [Google Scholar] [CrossRef] [PubMed]
[25] Ahn, Y.S. (1990) Efficacy of Danazol in Hematologic Disorders. Acta Haematologica, 84, 122-129. [Google Scholar] [CrossRef] [PubMed]
[26] Ahn, Y.S., Fernandez, L.F., Kim, C.I., Mylvaganam, R., Temple, J.D., Cayer, M.L., et al. (1989) Danazol Therapy Renders Red Cells Resistant to Osmotic Lysis. The FASEB Journal, 3, 157-162. [Google Scholar] [CrossRef] [PubMed]
[27] Ambríz, F., Pizzuto, J., Morales, M., Chávez, G., Guillén, C. and Avilés, A. (1987) Therapeutic Effect of Danazol on Metrorrhagia in Patients with Idiopathic Thrombocytopenic Purpura (ITP). Obstetrical & Gynecological Survey, 42, Article No. 704. [Google Scholar] [CrossRef] 
[28] Gandhi, V.D., Cephus, J., Norlander, A.E., Chowdhury, N.U., Zhang, J., Ceneviva, Z.J., et al. (2022) Androgen Receptor Signaling Promotes Treg Suppressive Function during Allergic Airway Inflammation. Journal of Clinical Investigation, 132, e153397. [Google Scholar] [CrossRef] [PubMed]
[29] Ikuta, K., Ejima, A., Abe, S. and Shimba, A. (2022) Control of Immunity and Allergy by Steroid Hormones. Allergology International, 71, 432-436. [Google Scholar] [CrossRef] [PubMed]
[30] Van Vollenhoven, R.F. and McGuire, J.L. (1994) Estrogen, Progesterone, and Testosterone: Can They Be Used to Treat Autoimmune Diseases? Cleveland Clinic Journal of Medicine, 61, 276-284. [Google Scholar] [CrossRef] [PubMed]
[31] Szekanecz, Z., Gomez, I., Soós, B., Bodoki, L., Szamosi, S., András, C., et al. (2020) Eight Pillars of Oncorheumatology: Crossroads between Malignancies and Musculoskeletal Diseases. Autoimmunity Reviews, 19, Article ID: 102658. [Google Scholar] [CrossRef] [PubMed]
[32] Giovanelli, L. and Quinton, R. (2022) Therapeutic Effects of Androgens for Cachexia. Best Practice & Research Clinical Endocrinology & Metabolism, 36, Article ID: 101598. [Google Scholar] [CrossRef] [PubMed]
[33] 中国抗癌协会肿瘤营养专业委员会. 肿瘤恶液质临床诊断与治疗指南(2020版) [J]. 中国肿瘤临床, 2021, 48(8): 379-385.
[34] Aboudkhil, S., Henry, L., Zaid, A., et al. (2005) Effect of Testosterone on Growth of P388 Leukemia Cell Line in Vivo and in Vitro. Distribution of Peripheral Blood T Lymphocytes and Cell Cycle Progression. Neoplasma, 52, 260-266.
[35] Lisukov, I.A., Tsyrlova, I.G. and Kozlov, V.A. (1986) Effect of Androgens on the Development of Leukemia in AKR-Strain Mice. Eksperimental’naia Onkologiia, 8, 71-73, 79.
[36] Blagosklonny, M.V. and Neckers, L.M. (1994) Cytostatic and Cytotoxic Activity of Sex Steroids against Human Leukemia Cell Lines. Cancer Letters, 76, 81-86. [Google Scholar] [CrossRef] [PubMed]
[37] Mossuz, P., Cousin, F., Castinel, A., Chauvet, M., Sotto, M., Polack, B., et al. (1998) Effects of Two Sex Steroids (17β Estradiol and Testosterone) on Proliferation and Clonal Growth of the Human Monoblastic Leukemia Cell Line, U937. Leukemia Research, 22, 1063-1072. [Google Scholar] [CrossRef] [PubMed]
[38] He, Q. and Jiang, D. (1999) A Novel Aminosteroid Is Active for Proliferation Inhibition and Differentiation Induction of Human Acute Myeloid Leukemia HL-60 Cells. Leukemia Research, 23, 369-372. [Google Scholar] [CrossRef] [PubMed]
[39] Danel, L., Martin, P., Escrich, E., Tubiana, N., Fiè, D. and Saez, S. (1981) Androgen, Estrogen and Progestin Binding Sites in Human Leukemic Cells. International Journal of Cancer, 27, 733-741. [Google Scholar] [CrossRef] [PubMed]
[40] Pigneux, A., Béné, M.C., Guardiola, P., Recher, C., Hamel, J., Sauvezie, M., et al. (2017) Addition of Androgens Improves Survival in Elderly Patients with Acute Myeloid Leukemia: A GOELAMS Study. Journal of Clinical Oncology, 35, 387-393. [Google Scholar] [CrossRef] [PubMed]
[41] Wiernik, P.H. (2018) Androgen Therapy for Acute Myeloid and Hairy Cell Leukemia. Current Treatment Options in Oncology, 19, Article No. 4. [Google Scholar] [CrossRef] [PubMed]
[42] 黄梓伦. 雄激素在血液病中的应用[J]. 中华内科杂志, 1990, 29(4): 239-242.
[43] Darke, S., Torok, M. and Duflou, J. (2014) Sudden or Unnatural Deaths Involving Anabolic‐Androgenic Steroids. Journal of Forensic Sciences, 59, 1025-1028. [Google Scholar] [CrossRef] [PubMed]
[44] Low, M.S.Y., Vilcassim, S., Fedele, P. and Grigoriadis, G. (2016) Anabolic Androgenic Steroids, an Easily Forgotten Cause of Polycythaemia and Cerebral Infarction. Internal Medicine Journal, 46, 497-499. [Google Scholar] [CrossRef] [PubMed]
[45] Rudy, R., Basree, M., Jacob, A. and Raj, R. (2024) Non-Ischemia Cardiomyopathy and Polycythemia Secondary to Anabolic-Androgenic Steroid Use. Cureus, 16, e66850. [Google Scholar] [CrossRef] [PubMed]
[46] Smit, D.L., Grefhorst, A., Buijs, M.M., Hon, O., Heijer, M. and Ronde, W. (2022) Prospective Study on Blood Pressure, Lipid Metabolism and Erythrocytosis during and after Androgen Abuse. Andrologia, 54, e14372. [Google Scholar] [CrossRef] [PubMed]
[47] Albano, G.D., Amico, F., Cocimano, G., Liberto, A., Maglietta, F., Esposito, M., et al. (2021) Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review. Healthcare, 9, Article No. 97. [Google Scholar] [CrossRef] [PubMed]
[48] Bond, P., Smit, D.L. and de Ronde, W. (2022) Anabolic-Androgenic Steroids: How Do They Work and What Are the Risks? Frontiers in Endocrinology, 13, Article ID: 1059473. [Google Scholar] [CrossRef] [PubMed]

为你推荐